arrow
Back
E

Eva Muñoz‐Couselo

Vall d'Hebron Institute of Oncology

33H-index
290Paper Count
4.8KCitation Count
Published Papers 71
Publication Date
Subcutaneous immunotherapy as a catalyst for decentralized, oncologist-led cancer care: a mixed-methods analysis
err2026-06-08
err0
errOAAI
errEva Muñoz-Couselo; Julia Lostes; Giulia Pretelli; Manel Peiró; Joan Barrubés; Xavier Bayona
errShare
errSave
Quality and safety of research biopsies in oncology clinical trials.
err2026-05-25
err0
errOAAI
errPaolo Nuciforo; Fiorella Ruiz-Pace; José Jimenez; Raquel Comas; Roberta Fasani; Cristina Viaplana; Cesar Sevillano; Paola Martinez; Xavier Serres-Créixams; Nuria Roson; Cristina Saura; Elena Elez; Ana Oaknin; Irene Braña Garcia; Eva Muñoz-Couselo; Teresa Macarulla Mercade; Joan Carles; Josep Tabernero; Enriqueta Felip; Elena Garralda
errShare
errSave
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma
err2026-04-01
err0
errOAAI
errDummer, Reinhard; Sandhu, Shahneen; Miller Jr, Wilson H.; Butler, Marcus O.; Taylor, Matthew H.; Heinzerling, Lucie; Blank, Christian U.; Couselo, Eva Munoz; Burris, Howard A.; Postow, Michael A.; Chmielowski, Bartosz; Middleton, Mark R.; Berking, Carola; Hassel, Jessica C.; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F.; Polli, Anna; Harney, Allison S.; Di Pietro, Alessandra; Ascierto, Paolo A.
errShare
errSave
Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801
err2025-12-20
err0
PREAI
errPablo Cerezuela-Fuentes; Antonio Piñero-Madrona; Eva Muñoz-Couselo; José Luis Manzano; Miguel-Ángel Berciano-Guerrero; Margarita Majem; Enrique Espinosa; Ainara Soria; Pablo Ayala de Miguel; Almudena García Castaño; Guillermo Crespo; Lourdes Gutiérrez Sanz; Carlos Aguado de la Rosa; Luis Antonio Fernández-Morales; Teresa Puértolas; Joaquín Fra Rodríguez; María Rodríguez de la Borbolla; Lorena Bellido; Rafael López Castro; Victor Navarro Pérez; Francisco Ramón García Arroyo; José Carlos Villa Guzmán; Begoña Campos Balea; Berta Hernández; Salvador Martín Algarra; Iván Márquez-Rodas
errShare
errSave
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study
err2025-12-01
err0
PREAI
errCerezuela-Fuentes, Pablo; Aguado de la Rosa, Carlos; Crespo, Guillermo; Berciano-Guerrero, Miguel-Angel; Soria, Ainara; Munoz-Couselo, Eva; Lopez Castro, Rafael; Majem, Margarita; Ayala de Miguel, Pablo; Manzano, Jose Luis; Bellido, Lorena; Lecumberri, Ma Jose; Corral Subias, Monica; Villa Guzman, Jose Carlos; Hernandez, Berta; Espinosa, Enrique; Puertolas, Teresa; Gutierrez Sanz, Lourdes; Medina Martinez, Javier; Palomar Abril, Vicente; Martin Algarra, Salvador; Marquez-Rodas, Ivan
errShare
errSave
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801
err2025-11-28
err0
errOAAI
errEnrique Espinosa; Miguel-Ángel Berciano-Guerrero; Eva Muñoz-Couselo; Teresa Puértolas; José Luis Manzano; Ainara Soria; Pablo Ayala de Miguel; Guillermo Crespo; Lourdes Gutiérrez Sanz; Pablo Cerezuela-Fuentes; Carlos Aguado de la Rosa; Margarita Majem; Almudena García Castaño; Alfonso Berrocal; Francisco Ramon García Arroyo; María Rodríguez de la Borbolla; Lorena Bellido; Javier Medina Martínez; Luis Antonio Fernández; Alfonso Martin Carnicero; Rafael López Castro; Aida Bujosa Rodríguez; Mª José Lecumberri; José Carlos Villa Guzmán; Begoña Campos Balea; Joaquín Fra Rodríguez; Javier Valdivia Bautista; Victor Navarro Pérez; Karmele Mujika; Mónica Corral Subias; Berta Hernández; Salvador Martín Algarra; Iván Márquez-Rodas
errShare
errSave
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
err2025-11-06
err0
errOAAI
errR. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero
errShare
errSave
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial
err2025-10-18
err0
errOAAI
errGeorgina V. Long; Charlie Garnett-Benson; Sonia Dolfi; Paolo A. Ascierto; Jun Guo; Ahmad A. Tarhini; Sunandana Chandra; Eva Muñoz-Couselo; Michele Del Vecchio; Andreia Cristina de Melo; Margaret Callahan; Helen Gogas; Reinhard Dummer; Dirk Schadendorf; Peter Koelblinger; Gaelle Quereux; Ioannis Thomas; Jia Xin Yu; Andrew Fisher; Bonnie Wang; Patrick Djidel; Armand Chouzy; Mark Semaan; Bohang Chen; Alicia M. Y. Cheong; Hussein A. Tawbi
errShare
errSave
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial
err2025-09-24
err0
errOAAI
errGeorgina V. Long; Nitya Nair; Daniel Marbach; Richard A. Scolyer; Sabine Wilson; Denise Cotting; Nicolas Staedler; Rodabe N. Amaria; Paolo Antonio Ascierto; Ahmad A. Tarhini; Caroline Robert; Omid Hamid; Caroline Gaudy-Marqueste; Celeste Lebbe; Eva Munoz-Couselo; Alexander M. Menzies; Cecile Pages; Giuseppe Curigliano; Mario Mandala; Nikki Jessop; Uwe Bader; Maurizio Perdicchio; Volker Teichgräber; Merlind Muecke; Christoph Markert; Christian Blank
errShare
errSave
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry
err2025-08-21
err0
PREAI
errMaria Gonzalez-Cao; Miguel-Ángel Berciano-Guerrero; Eva Muñoz-Couselo; José Luis Manzano; Pablo Cerezuela-Fuentes; Guillermo Crespo; Ainara Soria; Pablo Ayala de Miguel; Lourdes Gutiérrez Sanz; Carlos Aguado de la Rosa; Almudena García Castaño; Teresa Puértolas; Enrique Espinosa; Javier Medina; Lorena Bellido; Alfonso Berrocal; Margarita Majem; Rafael López Castro; Luis Antonio Fernandez; Francisco Garcia; Maria Rodriguez de la Borbolla; Salvador Martín Algarra; Iván Márquez-Rodas
errShare
errSave
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)
err2025-07-27
err0
PREAI
errPablo Ayala-de Miguel; Eva Muñoz-Couselo; Lourdes Gutiérrez-Sanz; Luis Antonio Fernández; Víctor Navarro-Pérez; Miguel Ángel Berciano-Guerrero; Francisco García-Arroyo; Carlos Aguado-de la Rosa; Pablo Cerezuela-Fuentes; Margarita Majem; Begoña Campos-Balea; Ainara Soria; Berta Hernández-Marín; Almudena García-Castaño; Salvador Martín-Algarra; Iván Márquez-Rodas
errShare
errSave
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study
err2025-06-09
err0
errOAAI
errMario Mandalà; Teresa Amaral; Piotr Rutkowski; Maria Chiara Sergi; Marie-Lena Rasch; Naima Benannoune; Patricio Serra; Maria Grazia Vitale; Diana Giannarelli; Ana Maria Arance; Eva Munoz Couselo; Bart Neyns; Iris Dirven; Marco Tucci; Michele Guida; Francesco Spagnolo; Ernesto Rossi; Paola Queirolo; Pietro Quaglino; Roberta Depenni; Paolo A. Ascierto
errShare
errSave
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study
err2025-05-28
err0
PREAI
errCaroline Robert; Michal Kicinski; Caroline Dutriaux; Émilie Routier; Anne-Sophie Govaerts; Emanuel Bührer; Eve-Marie Neidhardt; Xavier Durando; Barouyr Baroudjian; Philippe Saiag; Caroline Gaudy-Marqueste; Paolo A Ascierto; Ana Arance; Michelangelo Russillo; Jean-Luc Perrot; Laurent Mortier; Francois Aubin; Stéphane Dalle; Florent Grange; Eva Muñoz-Couselo; Alexander C J van Akkooi
errShare
errSave
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis
err2025-04-08
err0
PREAI
errS. Martín-Lluesma; U. Dafni; K. Vervita; D. Karlis; G. Dimopoulou; Z. Tsourti; G. Villacampa; V. Galvao; J. Lostes; E. Muñoz-Couselo; M. Rotxés; X. Villalobos; S. Muñoz; J.B.A.G. Haanen; I.M. Svane; J.M. Piulats; J. Martin-Liberal; A. Gros; G. Coukos; E. Garralda
errShare
errSave
Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study
err2025-03-11
err0
errOAAI
errDent, Rebecca; Cortes, Javier; Park, Yeon Hee; Munoz-Couselo, Eva; Kim, Sung-Bae; Sohn, Joohyuk; Im, Seock-Ah; Holgado, Esther; Foukakis, Theodoros; Kuemmel, Sherko; Yearley, Jennifer; Wang, Anran; Nebozhyn, Michael; Huang, Lingkang; Cristescu, Razvan; Jelinic, Petar; Karantza, Vassiliki; Schmid, Peter
errShare
errSave
Transcriptional reprogramming triggered by neonatal UV radiation or Lkb1 loss prevents BRAFV600E-induced growth arrest in melanocytes
err2025-03-08
err0
errOAAI
errMcgrail, Kimberley; Granado-Martinez, Paula; Orsenigo, Roberto; Caratu, Ginevra; Nieto, Paula; Heyn, Holger; Ferrer, Berta; Hernandez-Losa, Javier; Munoz-Couselo, Eva; Garcia-Patos, Vicenc; Recio, Juan A.
errShare
errSave
Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma
err2025-03-08
err0
errOAAI
errEva Muñoz Couselo; Carola Berking; Jean François Baurain; Serena Martelli; Ramon Arntz; Paola Savoia
errShare
errSave
Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial
err2025-02-26
err0
errOAAI
errSoria, Ainara; Maurino, Pedro Sanchez; Domingo, Juan Jose Serrano; Galindo, Regina Garcia; Sequero, Silvia; Sanz, Lourdes Gutierrez; Crespo, Guillermo; Diaz-Beveridge, Roberto; Puertolas, Teresa; Lopez, Pedro; Rodriguez, Joaquin Fra; Castro, Rafael Lopez; Aguayo, Cristina; Valdivia, Javier; Cunquero-Tomas, Alberto Jacobo; Benitez, Gretel; de Miguel, Pablo Ayala; Espinosa, Enrique; Munoz-Couselo, Eva; Campos, Begona; Sanchez, Lourdes Garcia; Cerezuela-Fuentes, Pablo
errShare
errSave
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWERCSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6
err2025-01-01
err3
PREAI
errHughes, Brett G. M.; Guminski, Alexander; Bowyer, Samantha; Migden, Michael R.; Schmults, Chrysalyne D.; Khushalani, Nikhil I.; Chang, Anne Lynn S.; Grob, Jean-Jacques; Lewis, Karl D.; Ansstas, George; Day, Fiona; Ladwa, Rahul; Stein, Brian N.; Couselo, Eva Munoz; Meier, Friedegund; Hauschild, Axel; Schadendorf, Dirk; Basset-Seguin, Nicole; Modi, Badri; Dalac-Rat, Sophie; Dunn, Lara A.; Flatz, Lukas; Mortier, Laurent; Guegan, Sarah; Heinzerling, Lucie M.; Mehnert, Janice M.; Trabelsi, Sabiha; Soria-Rivas, Ainara; Stratigos, Alexander J.; Ulrich, Claas; Wong, Deborah J.; Beylot-Barry, Marie; Bossi, Paolo; Sanchez, Cristina Buges; Chandra, Sunandana; Robert, Caroline; Russell, Jeffery S.; Silk, Ann W.; Booth, Jocelyn; Yoo, Suk-Young; Seebach, Frank; Lowy, Israel; Fury, Matthew G.; Rischin, Danny
errShare
errSave
Five latent factors underlie response to immunotherapy
err2024-09-12
err0
errOAAI
errUsset, Joseph; Huber, Axel Rosendahl; Andrianova, Maria A.; Batlle, Eduard; Carles, Joan; Cuppen, Edwin; Elez, Elena; Felip, Enriqueta; Gomez-Rey, Marina; Lo Giacco, Deborah; Martinez-Jimenez, Francisco; Munoz-Couselo, Eva; Siu, Lillian L.; Tabernero, Josep; Vivancos, Ana; Muinos, Ferran; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria
errShare
errSave